Iron homeostasis: A new job for macrophages in adipose tissue?

Trends in Endocrinology and Metabolism

Volumn 26, Issue 2, 2015, Pages 101-109

  Hubler, Merla J ^a   Peterson, Kristin R ^a   Hasty, Alyssa H ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Adipose tissue; Inflammation; Iron; Macrophage

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; CD163 ANTIGEN; FERRITIN; FERROPORTIN 1; GAMMA INTERFERON; HAPTOGLOBIN; HEME; HEME OXYGENASE 1; HEMOGLOBIN; HEMOPEXIN; HEPCIDIN; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANEMIA; ANEMIA OF CHRONIC DISEASE; ANTIINFLAMMATORY ACTIVITY; BIOGENESIS; BLEEDING; CELL POLARITY; CHRONIC DISEASE; CHRONIC INFLAMMATION; DIABETES MELLITUS; DIET INDUCED OBESITY; DYSMETABOLIC IRON OVERLOAD SYNDROME; ENDOCYTOSIS; ENDOSOME; ERYTHROPHAGOCYTOSIS; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE CELL; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; LIVER; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLIC REGULATION; MITOCHONDRION; MULTIPLE SCLEROSIS; NEOPLASM; NONHUMAN; OBESITY; PANCREAS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; WOUND HEALING; ANIMAL; HOMEOSTASIS; METABOLIC SYNDROME X; METABOLISM; PHYSIOLOGY;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; HOMEOSTASIS; HUMANS; IRON; IRON OVERLOAD; MACROPHAGES; METABOLIC SYNDROME X; OBESITY;

EID: 84923079489     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2014.12.005     Document Type: Review

References (88)

1. Bozzini C., et al. Prevalence of body iron excess in the metabolic syndrome. Diabetes care 2005, 28:2061-2063.
2. Gonzalez A.S., et al. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur. J. Clin. Nutr. 2006, 60:802-809.
3. Chang J.S., et al. Serum ferritin and risk of the metabolic syndrome: a population-based study. Asia Pac. J. Clin. Nutr. 2013, 22:400-407.
4. Jehn M., et al. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes care 2004, 27:2422-2428.
5. Iwasaki T., et al. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes care 2005, 28:2486-2491.
6. Simcox J.A., McClain D.A. Iron and diabetes risk. Cell Metab. 2013, 17:329-341.
7. Dongiovanni P., et al. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J. Hepatol. 2011, 55:920-932.
8. Basuli D., et al. Epidemiological associations between iron and cardiovascular disease and diabetes. Front. Pharmacol. 2014, 5:117.
9. Jiang R., et al. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004, 291:711-717.
10. Dongiovanni P., et al. Dietary iron overload induces visceral adipose tissue insulin resistance. Am. J. Pathol. 2013, 182:2254-2263.
11. Fernandez-Real J.M., et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes care 1998, 21:62-68.
12. Menzie C.M., et al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J. Am. Diet. Assoc. 2008, 108:145-148.
13. Haap M., et al. Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. Ann. Intern. Med. 2003, 139:869-871.
14. Wlazlo N., et al. Iron metabolism is prospectively associated with insulin resistance and glucose intolerance over a 7-year follow-up period: the CODAM study. Acta Diabetol. 2014, Published online October 1, 2014. 10.1007/s00592-014-0646-3.
15. Moreno-Navarrete J.M., et al. Insulin resistance modulates iron-related proteins in adipose tissue. Diabetes Care 2014, 37:1092-1100.
16. Fernandez-Real J.M., et al. Iron stores, blood donation, and insulin sensitivity and secretion. Clin. Chem. 2005, 51:1201-1205.
17. Trujillo M.E., Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocr. Rev. 2006, 27:762-778.
18. Winer S., Winer D.A. The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance. Immunol. Cell Biol. 2012, 90:755-762.
19. Gabrielsen J.S., et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J. Clin. Invest. 2012, 122:3529-3540.
20. Tussing-Humphreys L.M., et al. Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity (Silver Spring) 2010, 18:1449-1456.
21. Ganz T. Macrophages and systemic iron homeostasis. J. Innate Immun. 2012, 4:446-453.
22. Kohyama M., et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 2009, 457:318-321.
23. Shoden A., Sturgeon P. Iron storage IV. Cellular distribution of excess liver iron. Am. J. Pathol. 1962, 40:671-683.
24. Corhay J.L., et al. Iron content in human alveolar macrophages. Eur. Respir. J. 1992, 5:804-809.
25. Nemeth E., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
26. Frazer D.M., et al. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 2002, 123:835-844.
27. Bekri S., et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006, 131:788-796.
28. Wu X., et al. Hepcidin regulation by BMP signaling in macrophages is lipopolysaccharide dependent. PLoS ONE 2012, 7:e44622.
29. Nemeth E., Ganz T. The role of hepcidin in iron metabolism. Acta Haematol. 2009, 122:78-86.
30. Donovan A., et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell metab. 2005, 1:191-200.
31. Hosogai N., et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56:901-911.
32. Lakhal S., et al. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis. J. Biol. Chem. 2011, 286:4090-4097.
33. Tsuchiya H., et al. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metab. Clin. Exp. 2013, 62:62-69.
34. Chung J., et al. Diet-induced obesity leads to decreased hepatic iron storage in mice. Nutr. Res. 2011, 31:915-921.
35. Orr J.S., et al. Obesity alters adipose tissue macrophage iron content and tissue iron distribution. Diabetes 2013, 63:421-432.
36. Salgia R.J., Brown K. Diagnosis and management of hereditary hemochromatosis. Clin. Liver Dis. 2015, 19:187-198.
37. Drakesmith H., et al. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15602-15607.
38. Bugianesi E., et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 2004, 39:179-187.
39. Valenti L., et al. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. J. Hepatol. 2010, 53:927-933.
40. Wang J., Pantopoulos K. Regulation of cellular iron metabolism. Biochem. J. 2011, 434:365-381.
41. Moreno-Navarrete J.M., et al. Fine-tuned iron availability is essential to achieve optimal adipocyte differentiation and mitochondrial biogenesis. Diabetologia 2014, 57:1957-1967.
42. Rumberger J.M., et al. Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes. Diabetes 2004, 53:2535-2541.
43. Green A., et al. Transferrin and iron induce insulin resistance of glucose transport in adipocytes. Metabolism 2006, 55:1042-1045.
44. Murdolo G., et al. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance. Biochimie 2013, 95:585-594.
45. Levi S., Rovida E. The role of iron in mitochondrial function. Biochim. Biophys. Acta 2009, 1790:629-636.
46. Wilson-Fritch L., et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 2004, 114:1281-1289.
47. -/-) mouse. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E1236-E1243.
48. Wlazlo N., et al. Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study. Diabetes Care 2013, 36:309-315.
49. Ku B.J., et al. Serum ferritin is inversely correlated with serum adiponectin level: population-based cross-sectional study. Dis. Markers 2009, 27:303-310.
50. Kusminski C.M., Scherer P.E. Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol. Metab. 2012, 23:435-443.
51. Ponugoti B., et al. Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp. Diabetes Res. 2012, 2012:939751.
52. Nakae J., et al. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 2003, 4:119-129.
53. Lumeng C.N., et al. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007, 117:175-184.
54. Cho C.H., et al. Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ. Res. 2007, 100:e47-e57.
55. Nishimura S., et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 2007, 56:1517-1526.
56. + T cells in mice. Diabetes 2013, 62:2762-2772.
57. Nguyen K.D., et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011, 480:104-108.
58. Hill A.A., et al. A decade of progress in adipose tissue macrophage biology. Immunol. Rev. 2014, 262:134-152.
59. Weisberg S.P., et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
60. Cinti S., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 2005, 46:2347-2355.
61. Strissel K.J., et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007, 56:2910-2918.
62. Cairo G., et al. A precious metal: iron, an essential nutrient for all cells. Genes Nutr. 2006, 1:25-39.
63. Corna G., et al. Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 2010, 95:1814-1822.
64. Recalcati S., et al. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur. J. Immunol. 2010, 40:824-835.
65. Galleano M., et al. Nitric oxide and iron: effect of iron overload on nitric oxide production in endotoxemia. Mol. Aspects Med. 2004, 25:141-154.
66. Drapier J.C., et al. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J. 1993, 12:3643-3649.
67. Kroner A., et al. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 2014, 83:1098-1116.
68. Fried S.K., et al. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 1998, 83:847-850.
69. Wrighting D.M., Andrews N.C. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006, 108:3204-3209.
70. Gotardo E.M., et al. Mice that are fed a high-fat diet display increased hepcidin expression in adipose tissue. J. Nutr. Sci. Vitaminol. (Tokyo) 2013, 59:454-461.
71. Kim S., Ponka P. Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 2000, 275:6220-6226.
72. Orozco L.D., et al. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ. Res. 2007, 100:1703-1711.
73. Jais A., et al. Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man. Cell 2014, 158:25-40.
74. Kovtunovych G., et al. Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 2010, 116:6054-6062.
75. Sierra-Filardi E., et al. Heme oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 2010, 215:788-795.
76. Martinez F.O., et al. Macrophage activation and polarization. Front. Biosci. 2008, 13:453-461.
77. Etzerodt A., et al. Tumor necrosis factor alpha-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J. Leukocyte Biol. 2010, 88:1201-1205.
78. Sporrer D., et al. Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity. Eur. J. Clin. Invest. 2009, 39:671-679.
79. McDonald S.D., et al. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 2010, 341:c3428.
80. Bari M.F., et al. Elevated soluble CD163 in gestational diabetes mellitus: secretion from human placenta and adipose tissue. PLoS ONE 2014, 9:e101327.
81. Ohashi K., et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J. Biol. Chem. 2010, 285:6153-6160.
82. Thomsen J.H., et al. The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging. Oxid. Med. Cell. Longev. 2013, 2013:523652.
83. Boyle J.J., et al. Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am. J. Pathol. 2009, 174:1097-1108.
84. Finn A.V., et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J. Am. Coll. Cardiol. 2012, 59:166-177.
85. Bories G., et al. Liver X receptor activation stimulates iron export in human alternative macrophages. Circ. Res. 2013, 113:1196-1205.
86. Sindrilaru A., et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J. Clin. Invest. 2011, 121:985-997.
87. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889-896.
88. Mehta V., et al. Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS ONE 2013, 8:e57573.